The first study to test this new technology that started with COVID-19 vaccines will have sites in Rwanda and South Africa which are building on recent findings from a similar trial conducted among healthy adults in the US where researchers found vaccination induced the targeted immune responses in 97% of recipients.
A number of health professionals interviewed by URN attributed the low number of Ugandans seeking booster doses to the current trends of the disease. Dr Daniel Kyabayinze, the incident commander of COVID-19 Vaccination, says that only a few Ugandans are getting the booster dose because of the number of new infections.
Researchers say that investment in newer technologies and nutrition-sensitive innovations would help the country further reduce the complication which is also among the reasons for high maternal mortality in the country.
